Michelle Keefe - 17 Jan 2023 Form 4 Insider Report for Syneos Health, Inc.

Role
Chief Executive Officer, Director
Signature
/s/ Sara Epstein, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
17 Jan 2023
Net transactions value
-$162,582
Form type
4
Filing time
19 Jan 2023, 16:31:17 UTC
Previous filing
19 Dec 2022
Next filing
24 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SYNH Class A Common Stock Tax liability $123,676 -3,558 -3.3% $34.76 104,010 17 Jan 2023 Direct
transaction SYNH Class A Common Stock Award $0 +87,954 +85% $0.000000 191,964 17 Jan 2023 Direct F1
transaction SYNH Class A Common Stock Tax liability $38,906 -1,118 -0.58% $34.80 190,846 18 Jan 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted stock units which vests in three equal annual installments of 33 1/3% beginning on January 17, 2024, subject to continued employment.